DE69902526T2 - Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate - Google Patents

Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate

Info

Publication number
DE69902526T2
DE69902526T2 DE69902526T DE69902526T DE69902526T2 DE 69902526 T2 DE69902526 T2 DE 69902526T2 DE 69902526 T DE69902526 T DE 69902526T DE 69902526 T DE69902526 T DE 69902526T DE 69902526 T2 DE69902526 T2 DE 69902526T2
Authority
DE
Germany
Prior art keywords
oxazolidinone
improving
antibacterial effect
arginine derivatives
arginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902526T
Other languages
English (en)
Other versions
DE69902526D1 (de
Inventor
John Bohanon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69902526D1 publication Critical patent/DE69902526D1/de
Publication of DE69902526T2 publication Critical patent/DE69902526T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69902526T 1998-05-18 1999-05-13 Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate Expired - Fee Related DE69902526T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8116498A 1998-05-18 1998-05-18
PCT/US1999/007038 WO1999059616A1 (en) 1998-05-18 1999-05-13 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives

Publications (2)

Publication Number Publication Date
DE69902526D1 DE69902526D1 (de) 2002-09-19
DE69902526T2 true DE69902526T2 (de) 2003-04-03

Family

ID=22162494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902526T Expired - Fee Related DE69902526T2 (de) 1998-05-18 1999-05-13 Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate

Country Status (25)

Country Link
US (1) US6251869B1 (de)
EP (1) EP1077718B1 (de)
JP (1) JP2002515450A (de)
KR (1) KR20010043695A (de)
CN (1) CN1170584C (de)
AT (1) ATE222115T1 (de)
AU (1) AU746606B2 (de)
BR (1) BR9910443A (de)
CA (1) CA2327100A1 (de)
CZ (1) CZ291945B6 (de)
DE (1) DE69902526T2 (de)
DK (1) DK1077718T3 (de)
EA (1) EA003458B1 (de)
ES (1) ES2182521T3 (de)
HK (1) HK1036222A1 (de)
HU (1) HUP0101958A3 (de)
IL (1) IL139437A0 (de)
NO (1) NO20005813L (de)
NZ (1) NZ508256A (de)
PL (1) PL344049A1 (de)
PT (1) PT1077718E (de)
SK (1) SK283038B6 (de)
TR (1) TR200003384T2 (de)
WO (1) WO1999059616A1 (de)
ZA (1) ZA200005923B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
GB0005703D0 (en) * 2000-03-09 2000-05-03 Alpharma As Compounds
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
US20050255538A1 (en) * 2002-03-15 2005-11-17 Buxser Stephen E Methods for screening for AcrAB efflux pump inhibitors
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) * 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
CN1976703A (zh) * 2004-06-30 2007-06-06 诺瓦提斯公司 通过使用外排泵抑制剂增加肽脱甲酰基酶抑制剂敏感性的方法
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
EP1934208B1 (de) 2005-10-04 2011-03-23 Bayer Schering Pharma Aktiengesellschaft Neue polymorphe form von 5-chlor-n-({ ( 5s )-2-0x0-3-[4-( 3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl} -methyl)-2-thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US20170258816A1 (en) 2014-09-12 2017-09-14 Antibiotx Aps Antibacterial Use of Halogenated Salicylanilides
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
WO2020176067A1 (en) 2019-02-25 2020-09-03 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with h. pylori using a halogenated salicylanilide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989832A (en) * 1995-04-21 1999-11-23 Microcide Pharmaceuticals, Inc. Method for screening for non-tetracycline efflux pump inhibitors
KR20010021645A (ko) * 1997-07-11 2001-03-15 로렌스 티. 마이젠헬더 티아디아졸릴 및 옥사디아졸릴 페닐 옥사졸리디논 항균제
US6068972A (en) * 1997-10-03 2000-05-30 Trustees Of Tufts College Methods and compositions for reducing bacterial tolerance to antibacterials, disinfectants and organic solvents
US6790856B2 (en) * 2002-01-31 2004-09-14 Boehringer Ingelheim Pharma Kg Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

Also Published As

Publication number Publication date
DK1077718T3 (da) 2002-11-11
JP2002515450A (ja) 2002-05-28
WO1999059616A1 (en) 1999-11-25
ATE222115T1 (de) 2002-08-15
EP1077718B1 (de) 2002-08-14
BR9910443A (pt) 2001-01-02
US6251869B1 (en) 2001-06-26
NO20005813D0 (no) 2000-11-17
CZ291945B6 (cs) 2003-06-18
NZ508256A (en) 2003-08-29
HUP0101958A2 (hu) 2001-10-28
ES2182521T3 (es) 2003-03-01
EA200001197A1 (ru) 2001-04-23
TR200003384T2 (tr) 2001-03-21
IL139437A0 (en) 2001-11-25
KR20010043695A (ko) 2001-05-25
CZ20004259A3 (en) 2001-05-16
CN1170584C (zh) 2004-10-13
SK283038B6 (sk) 2003-02-04
AU746606B2 (en) 2002-05-02
PT1077718E (pt) 2002-12-31
PL344049A1 (en) 2001-09-24
DE69902526D1 (de) 2002-09-19
EP1077718A1 (de) 2001-02-28
HK1036222A1 (en) 2001-12-28
CN1297355A (zh) 2001-05-30
EA003458B1 (ru) 2003-06-26
NO20005813L (no) 2000-11-17
AU3860199A (en) 1999-12-06
HUP0101958A3 (en) 2003-07-28
SK16252000A3 (sk) 2001-06-11
CA2327100A1 (en) 1999-11-25
ZA200005923B (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DE69902526T2 (de) Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate
EA200300050A1 (ru) Гликопептидфосфонатные производные
EA200100411A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
FI956119A (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
ATE305793T1 (de) Bakteriophage mit breitem wirtspektrum
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
DE69725825D1 (de) 5-HT1F-Agonisten
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT1089625E (pt) Agentes ectoparasiticidas
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
EA200000092A1 (ru) Противоаллергические средства
BR0307085A (pt) Terapia combinada para o tratamento de infecções bacterianas
EA200000522A1 (ru) 5-htагонисты
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
DE69915688D1 (de) Benzonaphtyridin-1,8 derivate
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
CY1105981T1 (el) Ενωσεις 5-πυριδυλ-1,3-αζολιου, μεθοδοι παρασκευης αυτων και χρηση αυτων

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee